Report editions
This release
National Cervical Screening Program monitoring report 2022
Australian Institute of Health and Welfare (2022) National Cervical Screening Program monitoring report 2022, AIHW, Australian Government, accessed 23 April 2024. doi:10.25816/xz5f-vz10
Australian Institute of Health and Welfare. (2022). National Cervical Screening Program monitoring report 2022. Canberra: AIHW. doi:10.25816/xz5f-vz10
Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2022. AIHW, 2022. doi:10.25816/xz5f-vz10
Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2022. Canberra: AIHW; 2022. doi:10.25816/xz5f-vz10
Australian Institute of Health and Welfare 2022, National Cervical Screening Program monitoring report 2022, AIHW, Canberra. doi:10.25816/xz5f-vz10
PDF | 2Mb
This is the fourth report to monitor the National Cervical Screening Program since it introduced 5-yearly HPV tests in December 2017. In 2018–2021, more than 4.2 million people aged 25–74 participated, and in 2021, 11% of screening HPV tests performed were positive for HPV types that cause cervical cancer. Cervical cancer incidence and mortality remained low at 11 new cases and 2 deaths per 100,000 women, respectively.
More than 4.2 million cervical screening participants aged 25–74 in 2018–2021
Cervical screening test positivity was 11% in 2021
851 females aged 25–74 were diagnosed with cervical cancer in 2018
165 females aged 25–74 died from cervical cancer in 2020
National Cervical Screening Program monitoring report 2022